Calderome Inc., a Menlo Park, Calif.-based cancer diagnostics startup, has called down $11.9 million of a $23 million Series A round, according to a regulatory filing. Backers include Kleiner Perkins Caufield & Byers, TPG Biotechnology Partners and Versant Ventures. The company does not yet have a website.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.